CB
Cadence Bank’s GSK GSK Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $671K | Buy |
17,484
+504
| +3% | +$19.4K | 0.04% | 204 |
|
|
2025
Q1 | $658K | Buy |
16,980
+1
| +0% | +$39 | 0.05% | 198 |
|
|
2024
Q4 | $574K | Sell |
16,979
-10
| -0.1% | -$338 | 0.04% | 209 |
|
|
2024
Q3 | $695K | Sell |
16,989
-1,491
| -8% | -$61K | 0.05% | 194 |
|
|
2024
Q2 | $711K | Buy |
18,480
+570
| +3% | +$21.9K | 0.05% | 165 |
|
|
2024
Q1 | $768K | Buy |
17,910
+1,573
| +10% | +$67.4K | 0.06% | 186 |
|
|
2023
Q4 | $605K | Buy |
16,337
+1,655
| +11% | +$61.3K | 0.05% | 203 |
|
|
2023
Q3 | $532K | Buy |
14,682
+519
| +4% | +$18.8K | 0.05% | 207 |
|
|
2023
Q2 | $505K | Buy |
14,163
+5,174
| +58% | +$184K | 0.04% | 218 |
|
|
2023
Q1 | $320K | Buy |
8,989
+60
| +0.7% | +$2.14K | 0.03% | 263 |
|
|
2022
Q4 | $314K | Buy |
8,929
+634
| +8% | +$22.3K | 0.03% | 274 |
|
|
2022
Q3 | $244K | Buy |
+8,295
| New | +$244K | 0.03% | 295 |
|
|
2020
Q1 | – | Sell |
-5,637
| Closed | -$265K | – | 191 |
|
|
2019
Q4 | $265K | Buy |
5,637
+113
| +2% | +$5.31K | 0.05% | 174 |
|
|
2019
Q3 | $236K | Buy |
+5,524
| New | +$236K | 0.02% | 201 |
|
|
2019
Q2 | – | Sell |
-5,582
| Closed | -$233K | – | 227 |
|
|
2019
Q1 | $233K | Sell |
5,582
-1,638
| -23% | -$68.4K | 0.02% | 215 |
|
|
2018
Q4 | $276K | Sell |
7,220
-1,010
| -12% | -$38.6K | 0.03% | 191 |
|
|
2018
Q3 | $331K | Sell |
8,230
-868
| -10% | -$34.9K | 0.03% | 196 |
|
|
2018
Q2 | $367K | Buy |
9,098
+966
| +12% | +$39K | 0.03% | 179 |
|
|
2018
Q1 | $318K | Sell |
8,132
-1,000
| -11% | -$39.1K | 0.03% | 189 |
|
|
2017
Q4 | $324K | Buy |
+9,132
| New | +$324K | 0.03% | 190 |
|